THE USE OF PUBLISHED REAL-WORLD EVIDENCE IN HTA: AN ANALYSIS OF THE EVIDENCE BASE OF COMPANY SUBMISSIONS IN 2016 NICE APPRAISALS

被引：0
|
作者：
Van Lier, H. [1 ]
de Boeck, M. [1 ]
Edwards, V [1 ]
Hanekamp, E. [1 ]
Hartog, T. E. [1 ]
Richmond, G. [1 ]
van den Broek, R. [1 ]
机构：
[1] Excerpta Medica, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.076
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HT8
引用
收藏
页码：A410 / A410
页数：1
相关论文
共 50 条
  • [21] EVALUATION OF THE EXTENT OF REAL-WORLD EVIDENCE (RWE) USED WITHIN HEALTH TECHNOLOGY APPRAISALS (HTA) IN ONCOLOGY: A COMPARATIVE STUDY OF SIX HTA AGENCIES
    Harricharan, S.
    Curran, E.
    Lin, H. M.
    Walton, L. J.
    Gurjar, K.
    Nguyen, K.
    Forsythe, A.
    VALUE IN HEALTH, 2021, 24 : S44 - S44
  • [22] HEALTH TECHNOLOGY ASSESSMENT (HTA) CASE STUDIES: COMPARING ACCEPTABILITY OF REAL-WORLD EVIDENCE (RWE) IN APPRAISALS FOR ONCOLOGY MEDICINES
    Zong, J.
    Pan, X.
    Rojubally, A.
    Jiao, X.
    Bruno, A.
    Bergeson, J. Gdovin
    VALUE IN HEALTH, 2023, 26 (12) : S321 - S321
  • [23] WHAT IS THE VALUE OF REAL WORLD EVIDENCE IN ONCOLOGY IN HTA APPRAISALS IN ENGLAND, FRANCE, CANADA AND AUSTRALIA?
    Ng, T.
    Chawla, T.
    Bending, M. W.
    VALUE IN HEALTH, 2018, 21 : S64 - S64
  • [24] USING REAL-WORLD EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS: LESSONS AND INSIGHTS FROM REVIEW OF NICE'S TECHNOLOGY ASSESSMENT REPORTS (2016-2017)
    Aggarwal, S.
    Topaloglu, O.
    Kumar, S.
    VALUE IN HEALTH, 2018, 21 : S7 - S7
  • [25] Can requests for real-world evidence by the French HTA body be planned? An exhaustive retrospective case-control study of medicinal products appraisals from 2016 to 2021
    Fernandez, Judith
    Babin, Celeste
    Thomassin, Camille
    Pelon, Floriane
    Kelley, Sophie
    Cochat, Pierre
    Galbraith, Margaret
    Berdai, Driss
    Pariente, Antoine
    Salvo, Francesco
    Vanier, Antoine
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [26] THE USE OF PATIENT AND CARER PERSPECTIVES AND REAL-WORLD EVIDENCE IN ORPHAN DISEASE HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS
    Swift, S.
    Leadley, R. M.
    Hardy, E. J.
    Redhead, G.
    Withers, K.
    Peddle, A.
    Jenkins, A. R.
    Lang, S. H.
    VALUE IN HEALTH, 2024, 27 (12)
  • [27] REAL-WORLD EVIDENCE (RWE) TO SUPPORT REGULATORY SUBMISSIONS: LANDSCAPE ASSESSMENT & REVIEW
    Haris, G.
    Acha, V
    Liu, S.
    Burcu, M.
    VALUE IN HEALTH, 2023, 26 (06) : S213 - S213
  • [28] REAL-WORLD EVIDENCE IN THE CONTEXT OF HTA: ON THE EXAMPLE OF UTERINE FIBROIDS TREATMENT IN UKRAINE
    Piniazhko, O.
    Zaliska, O.
    VALUE IN HEALTH, 2016, 19 (07) : A904 - A904
  • [29] REAL-WORLD EVIDENCE ON THE RISE: EVALUATING THE USE OF REAL-WORLD EVIDENCE IN ICER ASSESSMENTS OF COMPARATIVE CLINICAL EFFECTIVENESS
    Drane, E.
    Upton, E.
    Morten, P.
    Walker, E.
    VALUE IN HEALTH, 2019, 22 : S316 - S316
  • [30] How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes - From Theory to Action
    Oortwijn, Wija
    Sampietro-Colom, Laura
    Trowman, Rebecca
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (04) : 346 - 350
12345